EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prevalence of Anti-Anisakis simplex Antibodies in a Cohort of Patients with Inflammatory Bowel Disease in Norway

María P de la Hoz-Martín, Juan González-Fernández iD, Juan Carlos Andreu-Ballester iD, Marte L Hoivik, Petr Ricanek, Torunn Bruland iD, Arne K Sandvik, Carmen Cuéllar iD, Ignacio Catalán-Serra iD

Pathogens · 2025

DOI: 10.3390/pathogens14080769 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, 2025. Verfasst von María P de la Hoz-Martín und 8 weiteren Autor:innen. Beteiligte Einrichtung: Unidad de Parasitología, Departamento de Microbiología y Parasitología, Facultad de Farmacia, Universidad Complutense de Madrid, 28040 Madrid, Spain. Hauptthemen laut MEDLINE: Anisakis, Antibodies, Helminth, Inflammatory Bowel Diseases, Anisakiasis. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study assessed the seroprevalence of anti-Anisakis simplex antibodies in Norwegian patients with inflammatory bowel disease (IBD), specifically ulcerative colitis (UC) and Crohn’s disease (CD), compared with healthy controls. Associations between anti-A. simplex antibody positivity and clinical or laboratory parameters in IBD were also explored. A total of 86 UC patients, 68 CD patients, and 41 healthy controls were prospectively enrolled from four Norwegian hospitals (2013–2022). Diagnosis and disease activity were established using standard clinical, endoscopic, and biomarker criteria. Serum samples were analyzed for total Ig, IgG, IgM, IgA, and IgE antibodies against A. simplex and Pseudoterranova decipiens using ELISA. Anti-A. simplex IgG seroprevalence was 4.9% in controls and 3.2% in IBD (3.5% UC, 2.9% CD). IgM seroprevalence was 0% in all groups. IgA seroprevalence was higher in IBD (16.2%) than controls (4.9%), with 14.0% in UC and 19.1% in CD. IgE seroprevalence was low across all groups. Smoking correlated with lower antibody levels and higher surgery rates. In UC, higher anti-A. simplex IgG and IgE levels were associated with milder disease and better prognosis. Anti-TNFα and azathioprine treatments were linked to higher anti-A. simplex IgA. Norwegian UC and CD patients had significantly higher anti-A. simplex total Ig and IgA seroprevalence than healthy controls, indicating increased exposure or immune response. Anti-A. simplex IgG and IgE may serve as markers of clinical activity in UC. Further research is warranted to clarify the clinical significance of these findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnisakisAntibodies, HelminthInflammatory Bowel DiseasesAnisakiasisHumansNorwayMaleFemaleAdultMiddle AgedSeroepidemiologic StudiesAnimalsImmunoglobulin GProspective StudiesImmunoglobulin EPrevalenceAgedImmunoglobulin AColitis, UlcerativeCrohn DiseaseYoung Adult

Stichwörter der Autor:innen

Anisakis simplexCrohn’s diseaseinflammatory bowel diseaseulcerative colitis

Substanzen

Antibodies, HelminthImmunoglobulin GImmunoglobulin EImmunoglobulin A

Autor:innen und Institutionen

  • Unidad de Parasitología, Departamento de Microbiología y Parasitología, Facultad de Farmacia, Universidad Complutense de Madrid, 28040 Madrid, Spain.
  • Fundación FISABIO-Salud Pública de Valencia, 46020 Valencia, Spain.
  • Department of Gastroenterology, Oslo University Hospital, 0424 Oslo, Norway.
  • Department of Gastroenterology, Division of Medicine, Akershus University Hospital, Lørenskog, and University of Oslo, 1478 Oslo, Norway.
  • Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, 7491 Trondheim, Norway.
  • Department of Gastroenterology, Levanger Hospital, Nord-Trøndelag Hospital Trust, 7600 Levanger, Norway.

ORCID-Profile: Juan González-Fernández, Juan Carlos Andreu-Ballester, Torunn Bruland, Carmen Cuéllar, Ignacio Catalán-Serra

Zitieren

APA

de la Hoz-Martín, M. P., González-Fernández, J., Andreu-Ballester, J. C., Hoivik, M. L., Ricanek, P., Bruland, T., Sandvik, A. K., Cuéllar, C., & Catalán-Serra, I. (2025). Prevalence of Anti-Anisakis simplex Antibodies in a Cohort of Patients with Inflammatory Bowel Disease in Norway. Pathogens. https://doi.org/10.3390/pathogens14080769

Vancouver

de la Hoz-Martín MP, González-Fernández J, Andreu-Ballester JC, Hoivik ML, Ricanek P, Bruland T, et al. Prevalence of Anti-Anisakis simplex Antibodies in a Cohort of Patients with Inflammatory Bowel Disease in Norway. Pathogens. 2025. doi:10.3390/pathogens14080769

BibTeX
@article{delaHozMartn2025,
  author = {de la Hoz-Martín, María P and González-Fernández, Juan and Andreu-Ballester, Juan Carlos and Hoivik, Marte L and Ricanek, Petr and Bruland, Torunn and Sandvik, Arne K and Cuéllar, Carmen and Catalán-Serra, Ignacio},
  title = {Prevalence of Anti-Anisakis simplex Antibodies in a Cohort of Patients with Inflammatory Bowel Disease in Norway},
  journal = {Pathogens},
  year = {2025},
  doi = {10.3390/pathogens14080769}
}
Kostenlos starten →